# Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey

> **NCT04594915** · — · COMPLETED · sponsor: **Daiichi Sankyo Turkey, a Daiichi Sankyo Company** · enrollment: 1053 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Edoxaban

## Key facts

- **NCT ID:** NCT04594915
- **Lead sponsor:** Daiichi Sankyo Turkey, a Daiichi Sankyo Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-14
- **Primary completion:** 2023-06-21
- **Final completion:** 2023-06-21
- **Target enrollment:** 1053 (ACTUAL)
- **Last updated:** 2023-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04594915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04594915, "Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04594915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*